Figure 6From: Development of dengue virus replicons expressing HIV-1 gp120 and other heterologous genes: a potential future tool for dual vaccination against dengue virus and HIVExpression of gp160 by Δpre-M/E-gp160 36 hours post transfection. Anti-dengue Serum was used in these experiments. Left and right panels are independent fields.Back to article page
